Edition:
India

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,579.00GBp
6:00pm IST
Change (% chg)

-4.00 (-0.06%)
Prev Close
6,583.00
Open
6,565.00
Day's High
6,595.00
Day's Low
6,523.00
Volume
253,323
Avg. Vol
1,418,611
52-wk High
7,174.00
52-wk Low
5,559.00

Latest Key Developments (Source: Significant Developments)

Indivior Says Case With U.S. DOJ Separate From That Of Reckitt
Thursday, 11 Jul 2019 

July 11 (Reuters) - Indivior PLC ::INDIVIOR PLC - INDIVIOR PROVIDES STATEMENT ON RB SETTLEMENT.INDIVIOR PLC - NOTES TODAY'S ANNOUNCEMENT OF RECKITT BENCKISER GROUP'S (RB) SETTLEMENT WITH VARIOUS US GOVERNMENT ENTITIES.INDIVIOR PLC - INDIVIOR PLC'S CASE WITH US DEPARTMENT OF JUSTICE (DOJ) IS SEPARATE FROM THAT OF RB.INDIVIOR PLC - INDIVIOR HAS NO ADDITIONAL OR NEW INFORMATION RELATED TO US DEPARTMENT OF JUSTICE MATTER.  Full Article

Reckitt Benckiser Names Pepsico Exec As CEO
Wednesday, 12 Jun 2019 

June 12 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER GP - RB CEO ANNOUNCEMENT.RECKITT BENCKISER GROUP PLC - APPOINTMENT OF LAXMAN NARASIMHAN AS CHIEF EXECUTIVE OFFICER TO SUCCEED RAKESH KAPOOR.RECKITT BENCKISER GROUP PLC - LAXMAN WILL SERVE AS GROUP CHIEF EXECUTIVE OFFICER AT RB, WHILE ALSO DIRECTLY LEADING HEALTH BUSINESS UNIT.RECKITT BENCKISER GROUP PLC - NARASIMHAN TO BE APPOINTED TO BOARD AS AN EXECUTIVE DIRECTOR EFFECTIVE 16 JULY 2019.  Full Article

Reckitt working toward resolving Indivior situation despite belief it's done nothing wrong - Chairman
Thursday, 9 May 2019 

May 9 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CEO STANDS BY FULL YEAR 2019 FORECAST.RECKITT BENCKISER CHAIRMAN SAYS COMPANY HAS DONE NOTHING WRONG AND SEES NO EVIDENCE OF IMPROPRIETY BY GROUP EMPLOYEES REGARDING INDIVIOR SITUATION.RECKITT CHAIRMAN SAYS COMPANY IS WORKING TOWARD RESOLUTION OF SITUATION.  Full Article

Reckitt Benckiser executive comments
Thursday, 2 May 2019 

May 2 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CEO SAYS DON'T EXPECT CONSISTENT 3-4 PERCENT LFL IN EVERY QUARTER OF YEAR.RECKITT BENCKISER CFO SAYS REASON FOR INDIVIOR-RELATED PROVISION WAS DUE TO UNCERTAINTIES AROUND INDEMNITY AND REIMBUSEMENT.  Full Article

Reckitt Benckiser Appoints Sara Mathew To Board As Non-Executive Director
Wednesday, 1 May 2019 

May 1 (Reuters) - Reckitt Benckiser Group PLC ::APPOINTMENT OF SARA MATHEW TO BOARD AS A NON-EXECUTIVE DIRECTOR, EFFECTIVE JULY 1.  Full Article

Reckitt Says U.S. DoJ's Indictment Of Indivior Not Against Co
Wednesday, 10 Apr 2019 

April 10 (Reuters) - Reckitt Benckiser Group PLC ::US JUSTICE DEPARTMENT INDICTMENT OF INDIVIOR PLC.NOTES 9 APRIL 2019 INDICTMENT BY US JUSTICE DEPARTMENT IN RELATION TO INDIVIOR PLC AND INDIVIOR INC.INDICTMENT NOT AGAINST CO OR ANY GROUP COMPANY AND CURRENTLY HAVE NO ADDITIONAL OR NEW INFORMATION IN RESPECT OF THE MATTER.REFERS INVESTORS TO STATEMENTS INCLUDING NOTE IN 2018 ANNUAL REPORT IN WHICH CO STATED THAT AT DEC 31, IT WAS RECOGNISING PROVISION OF $400M.  Full Article

Reckitt Benckiser Reports FY Adjusted Diluted EPS Of 339.9 Pence
Monday, 18 Feb 2019 

Feb 18 (Reuters) - Reckitt Benckiser Group PLC ::FY REVENUE ROSE 3 PERCENT TO 12.6 BILLION STG.FY ADJUSTED DILUTED EPS 339.9 PENCE.REMAIN ON TRACK TO ACHIEVE OUR INCREASED SYNERGY TARGET OF $300M..2019 LFL NET REVENUE GROWTH TARGETED AT +3-4%.QTRLY NET REVENUE FROM CONTINUING OPERATIONS 3,339 MILLION STG VERSUS 3,289 MILLION STG REPORTED LAST YEAR.ADJUSTED OPERATING MARGIN EXPECTED TO BE MAINTAINED IN 2019.FY NET REVENUE FROM CONTINUING OPERATIONS 12,597 MILLION STG VERSUS 11,512 MILLION STG REPORTED LAST YEAR.FY EARNINGS PER SHARE FROM CONTINUING OPERATIONS 305.5 PENCE.FY LIKE-FOR-LIKE NET REVENUE GROWTH FROM CONTINUING OPERATIONS OF +4% AT CONSTANT EXCHANGE.RECOMMENDS A FINAL DIVIDEND OF 100.2P PER SHARE (2017: 97.7P), AN INCREASE OF +3%..RECKITT BENCKISER GROUP - ALSO UNDER WAY IN THE SEARCH FOR A SUCCESSOR TO RAKESH KAPOOR, WHETHER INTERNAL OR EXTERNAL.MJN COST SYNERGIES IN 2018 WERE £158M ($211M) AND A CUMULATIVE TOTAL OF £178M ($236M) TO END OF 2018.RECKITT BENCKISER-IN 2019 EXPECT REMAINING SYNERGIES FROM MJN DEAL TO BE BROADLY OFFSET BY SMALL INCREASE IN OPERATING COSTS RELATED TO RB2.0 INFRASTRUCTURE.WILL TAKE UNTIL MID-2020 TO COMPLETE "INFRASTRUCTURE" CHANGES UNDER RB2.0.  Full Article

Reckitt Benckiser Says Rakesh Kapoor To Retire As CEO
Wednesday, 16 Jan 2019 

Jan 16 (Reuters) - Reckitt Benckiser Group PLC ::RAKESH KAPOOR TO RETIRE AS CEO BY END OF 2019.BOARD HAS INITIATED A SEARCH FOR NEW CEO AND IS CONSIDERING INTERNAL AND EXTERNAL CANDIDATES.  Full Article

Reckitt Benckiser sees no change to med-term profit guidance
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CEO SAYS WITHOUT MANUFACTURING DISRUPTION, INFANT NUTRITION WOULD HAVE BEEN UP 3 PERCENT YTD.RECKITT BENCKISER CEO SAYS AFFECTED FACILITY WAS IN THE NETHERLANDS, AND SUFFERED A TECHNICAL ENGINEERING ISSUE.RECKITT BENCKISER CFO SAYS NO CHANGE TO MEDIUM TERM MARGIN GUIDANCE.RECKITT BENCKISER CFO SAYS DOES NOT EXPECT ANY SUBSTANTIAL IMPACT ON BUSINESS FROM BREXIT.  Full Article

Glaxo Seeks Bids Mid-September For $4 Bln India Sale- Bloomberg
Tuesday, 21 Aug 2018 

Aug 21 (Reuters) - :GLAXO SEEKS BIDS MID-SEPTEMBER FOR $4 BILLION INDIA SALE- BLOOMBERG,CITING SOURCES.GLAXO'S INDIA SALE HAS ATTRACTED INTEREST FROM POTENTIAL BIDDERS INCLUDING NESTLE, PEPSICO AND RECKITT BENCKISER - BLOOMBERG,CITING SOURCES.  Full Article

Photo

Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment. | Video